Our analysis revealed that our major targets, including AKT1, EGFR, TNF, and ALB, are significantly involved in HCC resistance pathways, which suggests that targeting these genes may disturb the pathways that lead to HCC [46]. The gene discussed is EGFR; the disease is hepatocellular carcinoma.